The long term goals of this proposal are to understand the molecular mechanisms that regulate growth and development of smooth muscle in the bladder wall, and to determine the influence of sex hormones on the expression of smooth muscle specific phenotypes. An understanding of the cell differentiation and the biochemical regulation of muscle contraction is important to elucidate the pathogenetic mechanism(s) responsible for the differences in urinary bladder function in males and females.
The specific aims of this proposal are two-fold: (a) to understand the biochemical mechanisms that regulate the actin-myosin interaction and contraction of the smooth muscle in the rabbit bladder wall during growth and development, and (b) to see if there are any differences between males and females in the expression of smooth muscle myosin in the bladder during growth. The urinary bladder is an estrogen-sensitive organ. Ovariectomy and estrogen treatment are known to alter micturition and bladder contractility. Furthermore, while there are no differences in these parameters in immature male and female rats, after sexual maturity significant differences are seen between males and females. Therefore, the developmental changes which occur at sexual maturity have significant effects on bladder function, and the mechanisms responsible for the differences in bladder function observed between the sexes should be defined. Using specific antibodies for immunocytochemistry and cDNA probes for in situ hybridization, we will be able to determine if smooth muscle cells in the rabbit bladder during growth express myosin heavy chain isoforms SM1 (204 kDa) and SM2 (200 kDa) in the same ratio as in smooth muscle cells from other sources. These studies will enable us to characterize the muscle cells in the urinary bladder with respect to their contractile apparatus to determine if sex hormones and sexual maturity have any effects on the contractility of the bladder smooth muscle. This information will enable us to elucidate the pathogenetic mechanism(s) and pathophysiology associated with bladder disorders in females.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK047514-02
Application #
2147189
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Project Start
1993-09-30
Project End
1997-08-31
Budget Start
1994-09-01
Budget End
1995-08-31
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Pathology
Type
Schools of Veterinary Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Mannikarottu, Anita S; Changolkar, Arun K; Disanto, Michael E et al. (2005) Over expression of smooth muscle thin filament associated proteins in the bladder wall of diabetics. J Urol 174:360-4
Changolkar, Arun K; Hypolite, Joseph A; Disanto, Michael et al. (2005) Diabetes induced decrease in detrusor smooth muscle force is associated with oxidative stress and overactivity of aldose reductase. J Urol 173:309-13
Hypolite, J A; DiSanto, M E; Zheng, Y et al. (2001) Regional variation in myosin isoforms and phosphorylation at the resting tone in urinary bladder smooth muscle. Am J Physiol Cell Physiol 280:C254-64
Sanchez-Ortiz, R F; Wang, Z; Menon, C et al. (2001) Estrogen modulates the expression of myosin heavy chain in detrusor smooth muscle. Am J Physiol Cell Physiol 280:C433-40
Avrova, S V; Borovikov, Y S; Efimova, N N et al. (1998) Calcium modulates conformational changes in F-actin induced by smooth muscle heavy meromyosin. FEBS Lett 430:266-8
Menon, C; Chacko, S (1998) Expression of smooth muscle caldesmon in developing chicken gizzard. Tissue Cell 30:118-26
Chacko, S; DiSanto, M; Wang, Z et al. (1997) Contractile protein changes in urinary bladder smooth muscle during obstruction-induced hypertrophy. Scand J Urol Nephrol Suppl 184:67-76
Wang, Z; Jiang, H; Yang, Z Q et al. (1997) Both N-terminal myosin-binding and C-terminal actin-binding sites on smooth muscle caldesmon are required for caldesmon-mediated inhibition of actin filament velocity. Proc Natl Acad Sci U S A 94:11899-904
Wang, Z; Yang, Z Q; Chacko, S (1997) Functional and structural relationship between the calmodulin-binding, actin-binding, and actomyosin-ATPase inhibitory domains on the C terminus of smooth muscle caldesmon. J Biol Chem 272:16896-903
DiSanto, M E; Cox, R H; Wang, Z et al. (1997) NH2-terminal-inserted myosin II heavy chain is expressed in smooth muscle of small muscular arteries. Am J Physiol 272:C1532-42

Showing the most recent 10 out of 23 publications